PNLIP and hypertriglyceridemia: In conclusion, our study based on clinically approved omega-3 formulations for the treatment of severe hypertriglyceridemia, confirms the higher oral bioavailability, both at the systemic and target tissue levels, of the free carboxylic acid versus ethyl ester form of DHA, in a preclinical model of limited pancreatic lipase activity.